Based on information shared by valued members it looks like things are not right at parent Gelnmark Pharma. GLS 40% of revenues come from orders from parent. GLS has reported decline in orders from parent which is a red flag. I wonder if parent company is not in pink of health then what is fate of GLS?
Note: Invested since last 2 years (3% allocation)
| Subscribe To Our Free Newsletter |
